SANTA CLARA, Calif., April 16, 2013 /PRNewswire/ -- Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the signing of a Distribution Agreement with ATMI, Inc. (NASDAQ: ATMI), a global technology company and a leader in single-use process solutions. Over the last two years, and after several collaborative projects, the relationship between the companies has gained in strategic importance.
This agreement will allow both companies to offer customers seamless support for single-use bioreactor systems enabled by Finesse SmartSystems™, and ATMI's single-use Integrity® PadReactor™ bioreactor. The solution combines the optimized mixing and gas transfer performance of the space-efficient PadReactor system with the industry's leading bioreactor control platform and single-use sensors, namely, state-of-the-art TruFluor™ sensors for pH and dissolved oxygen and TruTorr™ sensors for pressure. The integrated system couples ATMI LifeScience's Integrity PadReactor bioreactor with Finesse's G3-series SmartControllers™ and TruBio® 4.X DV software, which are pre-configured for controlling process parameters such as pH, dissolved oxygen, temperature, agitation, gas/liquid flow and auxiliary analog inputs/loops.
The integrated ATMI-Finesse bioreactor system can be purchased in a single transaction with follow-on application and technical support from both ATMI and Finesse. Under the terms of the agreement, Finesse will offer fully-integrated turnkey systems for upstream bioprocessing. Additionally, ATMI will provide all post-point-of-sale customer requirements for PadReactor hardware and disposables while Finesse will support and service the controller, sensors and software.
"Based on the DeltaV® control platform from Em
|SOURCE Finesse Solutions, Inc.|
Copyright©2012 PR Newswire.
All rights reserved